ENZN
Enzon Pharmaceuticals, Inc.
1W: -7.7%
1M: +8886.6%
3M: +13505.4%
YTD: +16825.2%
1Y: +5399.5%
3Y: +2252.9%
5Y: +965.7%
$0.06
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.02-0.13
Volume207,734
Avg Volume73,774
Beta0.08
Dividend—
Analyst Ratings
No analyst coverage
Company Info
20 Commerce Drive
Cranford, NJ 07016
US
Cranford, NJ 07016
US
732 980 4500
About Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
Latest News
Enzon executes 1-for-100 reverse stock split ahead of merger
Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock
Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| WILLS STEPHEN T | 0 | — | 2025-01-07 | |
| READ RANDOLPH C | P-Purchase | 84,550 | $0.14 | 2023-06-16 |
| READ RANDOLPH C | P-Purchase | 15,000 | $0.13 | 2023-06-14 |
| Firestone Jaffrey Ad | 0 | — | 2022-06-09 | |
| COUCHMAN JONATHAN | S-Sale | 50,000 | $0.39 | 2021-08-13 |